Omsland A. et al. Host cell-free growth ofthe Q fever bacierium Coxiella burnetii // Proc. Natl. Acad, Sci. USA. 2009. V. 106. P. 4430–4434.
Ong C., Huey Ooi C., Wang D. et al. Patterns of large-scale genomic varianon in virulent and avirulent Burkholderia species // Genome Res. 2004. V. 14. P. 2295–2307.
Overholt E. L., Tigertt W. D., Kadull P. J. et al. An analysis of forty-two cases ot laboratory-acquired tularemia // Amer. J. Med. 1961. V. 30. № 5. P. 785–806.
Paessler S., Fayzulin R. Z., Anishchenko M. et al. Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic // J. Virol. 2003. V. 77. № 17. P. 9278–9286.
Paessler S., Yun N Е., Judy В. М. et al. Alpha-beta Т cells provide protecuon against lethal encephalitis in the murine model of VEEV infection // Virology. 2007. V. 367. № 2. 307–323.
Pahlitzsch R., Hammarin A., Widell A. A case of facial cellulitis and necrotizing lymphadenitis due to cowpox virus infection // Clin. Infec. Dis. 2006. V. 43. P. 737–742.
Palese P. RNA virus vectors: where are we and where do we need to go? // Proc. Natl. Acad. Sci. USA. 1998. V. 95 № 22. P. 12750-12752.
Pardo-Lypéz L., Comes I., Rausell С. et al. Structural changed of of the eCry1Ac oligomeric pre-pore from Bacillus thuringiensis // Biochemi. 2006. V. 45. P. 10329-10336.
Pardo-Lypéz L., Munoz-Garay C., Porta H. Strategies to improve the insecticidal activity of Cry toxins from Bacillus thuringiensis // Peptides. 2009 V 30. № 3. P. 589–595.
Pardridge W. M. Drug and gene targei.. ig to the brain with molecular Trojan horses // Nat. Rev. Drug Discov. 2002. V. l. P. 131–139.
Park K. W., Kim D.. ParkC.Y.etal Fatal systemic infection with multifocal liver and lung nodules caused by Brucella abortus // Am. J. Trop. Med. riyg. 2007. V. 77 № 6. P. 1120–1123.
Partikian A., Mitchell W. G. Iatrogenic botulism in a child with spastic quadriparesis // J. Child. Neurol. 2007. V. 22. № 10. P. 1235–1237.
Patcka J., Splino M., Mgrka V. Botulism and bioterrorism: how serious is this i iroblem? // Acta Memoa (Hradec Kralove). 2005. V. 48. № 1. P. 23–28.
Patra G., Vaissaire J. E., Weber-Levy M. et al, Molecular characteiization of Bacillus strains involved in outbreaks of Anthrax in France in 1997 // J. Clin. Microbiol. 1998. V. 36. № 11. P. 3412–3414.
Patric W. III. Biological warfare scenanos // Firepower in the Lab. Automat, in the Fight against Infect. Dis. and Bioter. / S. P. Layne (Eds.). Washington, D. C.: Joseph Henry Press. 7001. P. 215–223.
Pavlin J. A. Epidemiology of bioterronsm // Emerg. Infect. Dis. 1999. V. 5. № A P. 528–530.
Pavlov V. М., Mokrievich A. N. Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tuiarensis // FEMS Immunol. Med. Microbiol 1996. V. 13. P. 253—256
Paweska J., Sewlall N. H., Ksiazek T. J. et al. Nosocomial outbreak of novel arenavirus infection: Southern Africa // Emerg. Infect. Dis. 2009. V 15 № 10. P. 1598–1602.
Pearce L. B., First E. R., Maccallum R. D. et al. Pharmacologic characteiization of botulinum toxin for basic science and medicine // Toxicon. 1997. V. № 9. P. 1373–1412.
Pearson Т., Busch J. D., Ravel J. et al. Phylogenetic discovery bias in Bacillus anthracis using single-nucleou-Je polymorphisms from whole-genome sequencing // Proc. Natl. Acad. Sci. USA. 2004. V. 101. P. 13536-13541.
Pechous R., McCarthy T. R, Zahrt Т. C. Working toward the future insights into Francisella tuiarensis pathogenesis and vaccine development // Microbiol. Mol. Biol. Rev. 2009. V. 73. № 4. P. 684–711.
Peraica М., Radic B., Lucic A. et al. Toxic effects of mycotoxins in humans // Bulletin of the World Health Organization. 1999. V. 77. № 9. P. 754–766.
Pema N. Т., Mayhew G. F., Posfai G. et al. Molecular evolution of a pathogenicity island from entero-hemorrnagic Escherichia coll 0157:H7 // Infect Immun. 1998. V 66. P. 3810–3817.
Peter M. Bennett integrons and gene cassettes: a genetic construction kit for bacteria // J. Antirmcrob. Che-mother. 1999. V. 43. P. 1–4.
